Work

Phase I dose-escalation study of PSMA-targeted alpha emitter 225Ac-J591 in men with metastatic castration-resistant prostate cancer (mCRPC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.5560

Authors: Scott T. Tagawa, Joseph Osborne, Escarleth Fernandez, Charlene Thomas, Muhammad Junaid Niaz, Amy Ciriaco, Shankar Vallabhajosula, Panagiotis J. Vlachostergios, Ana M. Molina, Cora N. Sternberg, Sharon Singh, John Babich, David M. Nanus, Karla V. Ballman, Neil Harrison Bander

Institution: Weill Cornell Medicine

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3031908835

Cites:

Cited by: 10

Related to: 10